Insurers are cutting coverage for costly GLP-1 weight loss drugs, sparking backlash from advocates who say they’re vital for treating obesity.
The post As Insurers Drop GLP-1 Coverage, Advocates Search for a Hero in Obesity appeared first on MedCity News.
